Question 1

Am I eligible for this trial based on my current eye health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential risks and benefits of receiving Vitreosolve?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

Question 3

How does Vitreosolve compare to other treatments available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment process look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects clinical trial (NCT00664183). Contact the study team or your healthcare provider for specific answers.

What this study is about